EMP1 knockdown mitigated high glucose‐induced pyroptosis and oxidative stress in rat H9c2 cardiomyocytes by inhibiting the RAS/RAF/MAPK signaling pathway

Abstract The purpose of this study was to investigate the mechanism of EMP1 action in high glucose (HG)‐induced H9c2 cardiac cell pyroptosis and oxidative injury. Rat cardiomyocytes H9c2 were exposed to 33 mM glucose for 24, 48, or 72 h to induce cytotoxicity. EMP1‐siRNA, NLRP3 agonist Nigericin, and pcNDA‐RAS were used to treat H9c2 cells under HG conditions. Cell Counting Kit (CCK)‐8 assay showed that cell proliferation was decreased following HG induction, which was rescued by EMP1 knockdown. Our results also suggested that EMP1 siRNA transfection significantly decreased the apoptosis and pyroptosis of HG‐induced cells, as indicated by the reduction of NLRP3 IL‐1β, ASC, GSDMD, cleaved‐caspase1 and cleaved‐caspase3 levels in HG‐induced H9c2 cells. In addition, EMP1 knockdown alleviated HG‐induced mitochondrial damage and oxidative stress in H9c2 cells. NLRP3 activation reversed the inhibitory effects of EMP1 knockdown on pyroptosis and oxidative stress in HG‐induced H9c2 cells. Mechanistically, we found that EMP1 knockdown suppressed the RAS/RAF/MAPK signaling pathway in HG‐induced H9c2 cells. RAS overexpression blocked the protective effect of EMP1 knockdown on HG‐induced H9c2 cell apoptosis, pyroptosis, and oxidative injury. Our findings suggest that EMP1 knockdown treatment might provide a novel therapy for diabetic cardiomyopathy.